Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients.
Ricardo Jorge de Oliveira FerreiraPaco M J WelsingJohannes W G JacobsLaure GossecMwidimi NdosiPedro M MachadoDésirée Mfm van der HeijdeJosé António Pereira Da SilvaPublished in: Annals of the rheumatic diseases (2020)
4V-near-remission and 3V-remission have similar validity as the original 4V-remission definition in predicting GRO, despite expected worse prediction of GFO, while potentially reducing the risk of overtreatment. This supports further exploration of 3V-remission as the target for immunosuppressive therapy complemented by patient-oriented targets.